{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T10:07:26Z","timestamp":1779530846820,"version":"3.53.1"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Young Innovative Talents Project of The Affiliated Huaian No. 1 People\u00e2\u20ac\u2122s Hospital of Nanjing Medical University University","award":["QC202218"],"award-info":[{"award-number":["QC202218"]}]},{"name":"Key Laboratory Project of Autoimmune Diseases of Huaian City","award":["HAP202302"],"award-info":[{"award-number":["HAP202302"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,5]]},"abstract":"<jats:p>\n                    Recently, the relationship between cathepsins and a variety of diseases has gained increasing attention, especially various solid tumors and hematologic malignancies. However, there is no consensus on the causality between cathepsins and malignant lymphomas. The cathepsin genome-wide association studies (GWAS) dataset for this study was derived from THE INTERVAL STUDY and was freely downloaded via the OPENGWAS website. GWAS summary statistics for lymphomas were obtained from the FinnGen database. Single nucleotide polymorphisms satisfying the genome-wide association significance (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u20055\u2005\u00d7\u200510\n                    <jats:sup>\u22126<\/jats:sup>\n                    ) and linkage disequilibrium parameters (\n                    <jats:italic toggle=\"yes\">r<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    = 0.001 and clumping distance\u2005=\u200510,000\u2009kb) were screened for the subsequent 2-sample Mendelian randomization (MR) analysis. Sensitivity analyses were utilized to assess the stability and robustness of the MR conclusions. Genetically predicted Cathepsin S (CTSS) level was positively associated with the increased risk of diffuse large B cell lymphoma (DLBCL). Patients with elevated levels of CTSS are more susceptible to DLBCL, which corresponds to a 20.6% increased hazard (odds ratio inverse variance weighted [OR\n                    <jats:sub>IVW<\/jats:sub>\n                    ]\u2005=\u20051.206, 95% confidence interval [CI] 1.054\u20131.380,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.006). The causal role of the remaining cathepsins in DLBCL and other types of lymphoma was not established. No reverse causality between DLBCL and CTSS was observed after the backward MR analysis (OR\n                    <jats:sub>IVW<\/jats:sub>\n                    \u2005=\u20051.076, 95% CI 0.984\u20131.177,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.109). The multivariate MR results supported that CTSS was causally responsible for DLBCL (OR\n                    <jats:sub>IVW<\/jats:sub>\n                    \u2005=\u20051.204, 95% CI 1.042\u20131.392,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.012, OR\n                    <jats:sub>MR-Egger<\/jats:sub>\n                    \u2005=\u20051.200, 95% CI 1.038\u20131.387,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.014). This study demonstrated a causal effect of CTSS on DLBCL based on the MR algorithm. Follow-up studies are needed to elucidate the underlying mechanisms between them and explore promising new therapeutic options for DLBCL patients.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000046485","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T22:02:39Z","timestamp":1764972159000},"page":"e46485","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Cathepsins effect on diffuse large B cell lymphoma risk: A Mendelian randomization study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7640-5774","authenticated-orcid":false,"given":"Chuanyang","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Hematology, The Affiliated Huaian No.1 People\u2019s Hospital of Nanjing Medical University, Huaian, Jiangsu Province, China"},{"name":"Key Laboratory of Autoimmune Diseases of Huaian City, Huaian, Jiangsu Province, China"},{"name":"Key Laboratory of Hematology of Nanjing Medical University, Nanjing, Jiangsu Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuni","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Affiliated Huaian No.1 People\u2019s Hospital of Nanjing Medical University, Huaian, Jiangsu Province, China"},{"name":"Key Laboratory of Autoimmune Diseases of Huaian City, Huaian, Jiangsu Province, China"},{"name":"Key Laboratory of Hematology of Nanjing Medical University, Nanjing, Jiangsu Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuye","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Affiliated Huaian No.1 People\u2019s Hospital of Nanjing Medical University, Huaian, Jiangsu Province, China"},{"name":"Key Laboratory of Autoimmune Diseases of Huaian City, Huaian, Jiangsu Province, China"},{"name":"Key Laboratory of Hematology of Nanjing Medical University, Nanjing, Jiangsu Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Affiliated Huaian No.1 People\u2019s Hospital of Nanjing Medical University, Huaian, Jiangsu Province, China"},{"name":"Key Laboratory of Autoimmune Diseases of Huaian City, Huaian, Jiangsu Province, China"},{"name":"Key Laboratory of Hematology of Nanjing Medical University, Nanjing, Jiangsu Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunling","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Affiliated Huaian No.1 People\u2019s Hospital of Nanjing Medical University, Huaian, Jiangsu Province, China"},{"name":"Key Laboratory of Autoimmune Diseases of Huaian City, Huaian, Jiangsu Province, China"},{"name":"Key Laboratory of Hematology of Nanjing Medical University, Nanjing, Jiangsu Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0803-5801","authenticated-orcid":false,"given":"Liang","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Affiliated Huaian No.1 People\u2019s Hospital of Nanjing Medical University, Huaian, Jiangsu Province, China"},{"name":"Key Laboratory of Autoimmune Diseases of Huaian City, Huaian, Jiangsu Province, China"},{"name":"Key Laboratory of Hematology of Nanjing Medical University, Nanjing, Jiangsu Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260523","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41408-023-00853-3","article-title":"Global burden of hematologic malignancies and evolution patterns over the past 30 years.","volume":"13","author":"Zhang","year":"2023","journal-title":"Blood Cancer J"},{"key":"R2-20260523","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R3-20260523","doi-asserted-by":"crossref","first-page":"102370","DOI":"10.1016\/j.eclinm.2023.102370","article-title":"Estimates of the global burden of non-Hodgkin lymphoma attributable to HIV: a population attributable modeling study.","volume":"67","author":"Chen","year":"2024","journal-title":"EClinicalMedicine"},{"key":"R4-20260523","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3390\/cancers14061453","article-title":"DLBCL 1L-what to expect beyond R-CHOP?","volume":"14","author":"Stegemann","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R5-20260523","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nrc4027","article-title":"Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response.","volume":"15","author":"Olson","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"R6-20260523","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.3389\/fimmu.2019.02037","article-title":"Cysteine cathepsins in tumor-associated immune cells.","volume":"10","author":"Jakos","year":"2019","journal-title":"Front Immunol"},{"key":"R7-20260523","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tips.2007.10.011","article-title":"Cysteine cathepsin proteases as pharmacological targets in cancer.","volume":"29","author":"Palermo","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"R8-20260523","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/prca.201300085","article-title":"Cysteine cathepsins and their potential in clinical therapy and biomarker discovery.","volume":"8","author":"Fonovic","year":"2014","journal-title":"Proteomics Clin Appl"},{"key":"R9-20260523","doi-asserted-by":"crossref","first-page":"1428433","DOI":"10.3389\/fendo.2024.1428433","article-title":"Cathepsins and cancer risk: a Mendelian randomization study.","volume":"15","author":"Deng","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R10-20260523","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1002\/jcp.29710","article-title":"Prognostic role and therapeutic susceptibility of cathepsin in various types of solid tumor and leukemia: a systematic review.","volume":"235","author":"Hadad","year":"2020","journal-title":"J Cell Physiol"},{"key":"R11-20260523","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians.","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"R12-20260523","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/ejh.12513","article-title":"Genetic susceptibility to diffuse large B-cell lymphoma in a pooled study of three Eastern Asian populations.","volume":"95","author":"Bassig","year":"2015","journal-title":"Eur J Haematol"},{"key":"R13-20260523","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/ng.3105","article-title":"Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.","volume":"46","author":"Cerhan","year":"2014","journal-title":"Nat Genet"},{"key":"R14-20260523","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1155\/2010\/465040","article-title":"High expression of cathepsin D in non-Hodgkin\u2019s lymphomas negatively impacts on clinical outcome.","volume":"28","author":"Nicotra","year":"2010","journal-title":"Dis Markers"},{"key":"R15-20260523","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","article-title":"Genomic atlas of the human plasma proteome.","volume":"558","author":"Sun","year":"2018","journal-title":"Nature"},{"key":"R16-20260523","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population.","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"R17-20260523","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","article-title":"Non-Hodgkin lymphoma.","volume":"380","author":"Shankland","year":"2012","journal-title":"Lancet"},{"key":"R18-20260523","doi-asserted-by":"crossref","first-page":"a034819","DOI":"10.1101\/cshperspect.a034819","article-title":"Epidemiology and etiology of leukemia and lymphoma.","volume":"10","author":"Bispo","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R19-20260523","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R20-20260523","doi-asserted-by":"crossref","first-page":"e1003288","DOI":"10.1371\/journal.pmed.1003288","article-title":"Genetics of height and risk of atrial fibrillation: a mendelian randomization study.","volume":"17","author":"Levin","year":"2020","journal-title":"PLoS Med"},{"key":"R21-20260523","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/0962280210394459","article-title":"Using multiple genetic variants as instrumental variables for modifiable risk factors.","volume":"21","author":"Palmer","year":"2012","journal-title":"Stat Methods Med Res"},{"key":"R22-20260523","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R23-20260523","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data.","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"R24-20260523","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/ebmental-2019-300085","article-title":"Using Mendelian randomisation to assess causality in observational studies.","volume":"22","author":"Pagoni","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"R25-20260523","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R26-20260523","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.clnu.2023.06.028","article-title":"Association between intake of the n-3 polyunsaturated fatty acid docosahexaenoic acid (n-3 PUFA DHA) and reduced risk of ovarian cancer: a systematic Mendelian Randomization study.","volume":"42","author":"Zhang","year":"2023","journal-title":"Clin Nutr"},{"key":"R27-20260523","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/aje\/kwu283","article-title":"Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects.","volume":"181","author":"Burgess","year":"2015","journal-title":"Am J Epidemiol"},{"key":"R28-20260523","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/ije\/dyy262","article-title":"An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings.","volume":"48","author":"Sanderson","year":"2019","journal-title":"Int J Epidemiol"},{"key":"R29-20260523","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/PPO.0000000000000451","article-title":"Lymphoma classification.","volume":"26","author":"de Leval","year":"2020","journal-title":"Cancer J"},{"key":"R30-20260523","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.gendis.2022.12.008","article-title":"Targeting CD47-SIRPalpha axis for Hodgkin and non-Hodgkin lymphoma immunotherapy.","volume":"11","author":"Zhao","year":"2024","journal-title":"Genes Dis"},{"key":"R31-20260523","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1182\/blood.2023021346","article-title":"Epstein-Barr virus encoded EBNA2 downregulates ICOSL by inducing miR-24 in B-cell lymphoma.","volume":"143","author":"Leopizzi","year":"2024","journal-title":"Blood"},{"key":"R32-20260523","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood.2020005469","article-title":"Hematologic cancers in individuals infected by HIV.","volume":"139","author":"Carbone","year":"2022","journal-title":"Blood"},{"key":"R33-20260523","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/aps.2017.17","article-title":"Human T-cell lymphotropic virus type 1 and its oncogenesis.","volume":"38","author":"Zhang","year":"2017","journal-title":"Acta Pharmacol Sin"},{"key":"R34-20260523","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","article-title":"Helicobacter pylori infection.","volume":"9","author":"Malfertheiner","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"R35-20260523","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1080\/09603123.2023.2251406","article-title":"The association of COVID-19 with diffuse large B-cell lymphoma: a Mendelian randomization study.","volume":"34","author":"Chen","year":"2023","journal-title":"Int J Environ Health Res"},{"key":"R36-20260523","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/1547691X.2013.798388","article-title":"Immunomodulation and lymphoma in humans.","volume":"11","author":"Ponce","year":"2014","journal-title":"J Immunotoxicol"},{"key":"R37-20260523","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/ijc.24287","article-title":"Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies.","volume":"125","author":"Anderson","year":"2009","journal-title":"Int J Cancer"},{"key":"R38-20260523","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semcancer.2013.12.001","article-title":"Lymphoma development in patients with autoimmune and inflammatory disorders--what are the driving forces?","volume":"24","author":"Baecklund","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"R39-20260523","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.3390\/jcm9113403","article-title":"The role of autoimmune diseases in the prognosis of lymphoma.","volume":"9","author":"Masciopinto","year":"2020","journal-title":"J Clin Med"},{"key":"R40-20260523","doi-asserted-by":"crossref","first-page":"123097","DOI":"10.1016\/j.envpol.2023.123097","article-title":"Long-term exposure to ambient air pollution and risk of leukemia and lymphoma in a pooled European cohort.","volume":"343","author":"Taj","year":"2023","journal-title":"Environ Pollut"},{"key":"R41-20260523","doi-asserted-by":"crossref","first-page":"102443","DOI":"10.1016\/j.ctrv.2022.102443","article-title":"Treatment strategies for patients with diffuse large B-cell lymphoma.","volume":"110","author":"Poletto","year":"2022","journal-title":"Cancer Treat Rev"},{"key":"R42-20260523","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies.","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J"},{"key":"R43-20260523","doi-asserted-by":"crossref","first-page":"101106","DOI":"10.1016\/j.mam.2022.101106","article-title":"Cathepsin S (CTSS) activity in health and disease - a treasure trove of untapped clinical potential.","volume":"88","author":"Smyth","year":"2022","journal-title":"Mol Aspects Med"},{"key":"R44-20260523","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10549-016-4027-1","article-title":"Up-regulation of cathepsin S expression by HSP90 and 5-HT(7) receptor-dependent serotonin signaling correlates with triple negativity of human breast cancer.","volume":"161","author":"Gautam","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"R45-20260523","doi-asserted-by":"crossref","first-page":"109811","DOI":"10.1016\/j.cbi.2022.109811","article-title":"ASPER-29 suppresses the metastasis of pancreatic cancer cells by dual inhibition of cathepsin-L and cathepsin-S.","volume":"353","author":"Yuan","year":"2022","journal-title":"Chem Biol Interact"},{"key":"R46-20260523","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1517\/13543776.2011.553800","article-title":"Cathepsin S inhibitors: 2004-2010.","volume":"21","author":"Lee-Dutra","year":"2011","journal-title":"Expert Opin Ther Pat"},{"key":"R47-20260523","doi-asserted-by":"crossref","first-page":"109849","DOI":"10.1016\/j.abb.2023.109849","article-title":"Rational design of humanized antibody inhibitors for cathepsin S.","volume":"751","author":"Yu","year":"2024","journal-title":"Arch Biochem Biophys"},{"key":"R48-20260523","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ccell.2020.03.016","article-title":"Cathepsin S regulates antigen processing and T cell activity in non-hodgkin lymphoma.","volume":"37","author":"Dheilly","year":"2020","journal-title":"Cancer Cell"},{"key":"R49-20260523","doi-asserted-by":"crossref","first-page":"118781","DOI":"10.1016\/j.bbamcr.2020.118781","article-title":"Leading the invasion: the role of Cathepsin S in the tumour microenvironment.","volume":"1867","author":"McDowell","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"R50-20260523","doi-asserted-by":"crossref","first-page":"107522","DOI":"10.1016\/j.celrep.2020.107522","article-title":"Cathepsin S alterations induce a tumor-promoting immune microenvironment in follicular lymphoma.","volume":"31","author":"Bararia","year":"2020","journal-title":"Cell Rep"},{"key":"R51-20260523","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.3390\/cells9092021","article-title":"Novel opportunities for cathepsin S inhibitors in cancer immunotherapy by nanocarrier-mediated delivery.","volume":"9","author":"Fuchs","year":"2020","journal-title":"Cells"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046485","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T10:02:49Z","timestamp":1779530569000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":51,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046485","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"2025-08-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}